Gastrointestinal Conditions: Linaclotide (Linzess) and Plecanatide (Trulance) treat IBS and chronic constipation by acting on fluid secretion in the gut
Cagrilintide and semaglutide work through different mechanisms and have different dosing schedules: Cagrilintide: Amylin receptor agonist Escalation: 0.6 mg 1.2 mg 2.4 mg weekly Three-step titration over 8 weeks Semaglutide: GLP-1 receptor agonist Escalation: 0.25 mg 0.5 mg 1.0 mg 1.7 mg 2.4 mg weekly Five-step titration over 16-20 weeks When combined in CagriSema, both peptides are dosed at 2.4 mg weekly, representing the maximum studied dose for each component
This is a common concern, and the clinical reality is that without a maintenance phase, some weight regain is possible because the bodys natural hunger signals will return
Our Glutathione IV therapy is designed to help you achieve your health goals, from enhancing your physical appearance to boosting your overall energy and vitality, while our broader, more synergistic approach to anti-aging and longevity offers you a path to a better you
The entire gastrointestinal tract moves more sluggishly during GLP-1 therapy
Side effects and medical concerns Muscle Loss: A meaningful portion of the weight loss is coming from muscle mass, which can be harmful, especially for older adults or frail individuals